Syringes Market Size Worth $25.7 Billion by 2026 | CAGR: 8.5%: Grand View Research, Inc.
SAN FRANCISCO, Dec. 17, 2019 /PRNewswire/ -- The global syringes market size is expected to reach USD 25.7 billion by 2026, expanding at a CAGR of 8.5%, according to a new report by Grand View Research, Inc. The rising prevalence of chronic diseases, increasing number of surgical procedures, growing adoption of injectable drugs, favorable initiatives taken by government organizations, and increasing geriatric population across the globe are the key driving factors for the market.
https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg
Key suggestions from the report:
-- By product, the general segment held the largest market share in 2018 as
they are commonly used for various conditions such as tetanus and
vaccination
-- Disposable needles held the largest market share in 2018 and are
anticipated to witness the fastest growth over the forecast period as
they reduce the risk of contamination, significantly
-- The hospital segment held the largest market share owing to the
increasing number of chronic disease patients and rising number of
surgeries
-- The Asia Pacific market is expected to witness the fastest growth over
the forecast period owing to the rising demand for vaccines and
immunization in this region
-- Prominent players in the syringes market are BD; Smiths Medical; B.
Braun Melsungen AG; NIPRO Medical Corporation; Hindustan Syringes and
Medical Devices Ltd.; Gerresheimer AG; SCHOTT AG; CODAN Medizinische
Geräte GmbH and Co KG; McKesson Medical-Surgical Inc.; and Cardinal
Health. The key players are adopting various strategies such as product
launch, partnership, and merger and acquisition to strengthen their
foothold in the market.
Read 123 page research report with ToC on "Syringes Market Size, Share & Trends Analysis Report By Product (General, Specialized, Smart), By Usage (Reusable, Disposable), By End Use (Hospitals, Blood Collection Centers), By Region, And Segment Forecasts, 2019 - 2026'' at: https://www.grandviewresearch.com/industry-analysis/syringes-market
Chronic inflammatory diseases such as Crohn's disease and rheumatoid arthritis can be treated through self-administration of drugs. For instance, as per the U.S. Department of Health and Human Services, in 2015, approximately 3.0 million people were diagnosed with either Crohn's disease or ulcerative colitis, which was a huge increase from 2.0 million people in 1999. In addition, as per the Arthritis Foundation, arthritis is the major cause of disability in the U.S. It also reported that in 2019, approximately 54.0 million adults have been diagnosed with arthritis by the doctors, which is anticipated to increase to more than 78.0 million by 2040.
North America accounted for highest syringes market share in 2018 attributed to advent of technologically advanced medical devices and growing prevalence of chronic diseases. In addition, presence of major players in the region contributed to regional growth. Prominent players operating the region include Thomas Scientific; Smiths Medical; BD; Cardinal Health; McKesson Medical-Surgical Inc.; and B. Braun Melsungen AG.
Moreover, key companies such as BD and Smiths Medical, are launching products specifically for chronic disease treatment to strengthen their foothold in the industry. For instance, BD offers Hypak SCF PRTC glass pre-fillable syringe, used in the treatment of chronic diseases. Such factors are anticipated to boost the industry growth over the forecast period.
Grand View Research has segmented the global syringes market based on product, usage, end use, and region:
Syringes Product Outlook (Revenue, USD Million, 2015 - 2026)
-- General Syringes
-- Specialized Syringes
-- Insulin
-- Tuberculin (TB)
-- Allergy
-- Smart Syringes
-- Auto-Disable
-- Active Safety
-- Passive Safety
Syringes Usage Outlook (Revenue, USD Million, 2015 - 2026)
-- Reusable Syringes
-- Disposable Syringes
-- Empty
-- Prefilled
Syringes End-use Outlook (Revenue, USD Million, 2015 - 2026)
-- Hospitals
-- Blood Collection Centers
-- Diabetic Care Centers
-- Others
Syringes Regional Outlook (Revenue, USD Million, 2015 - 2026)
-- North America
-- U.S.
-- Canada
-- Europe
-- Germany
-- U.K.
-- Asia Pacific
-- China
-- Japan
-- Latin America
-- Brazil
-- Mexico
-- Middle East & Africa
-- South Africa
-- Saudi Arabia
Find more research reports on Medical Devices Industry, by Grand View Research:
-- Prefilled Syringes Market - The global prefilled syringes market size
was valued at USD 8.6 billion in 2016 and is projected to expand at a
CAGR of 11.2% over the forecast period.
-- Disposable Syringes Market - The global disposable syringes market size
was valued at USD 6.4 billion in 2015. The market is expected to grow
due to growing demand for injectable drugs.
-- Smart Syringes Market - The global smart syringes market was valued at
USD 4.75 billion in 2015. The high growth is anticipated on account of
the increasing prevalence of various target diseases.
Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
View original content:http://www.prnewswire.com/news-releases/syringes-market-size-worth-25-7-billion-by-2026--cagr-8-5-grand-view-research-inc-300975795.html
SOURCE Grand View Research, Inc.
